These Stocks Moved the Most Today: Intel, Home Depot, Palo Alto, Viking Therapeutics, Palantir, Medtronic, and More

An image from the floor of the New York Stock Exchange. (Michael M. Santiago/Getty Images)

Stocks end the day mixed on Tuesday, with the Nasdaq Composite index falling sharply as investors moved money out of highflying tech stocks.

These stocks made moves:

Intel rose 7% after an announcement that SoftBank would invest $2 billion in the chip maker. That followed a decline of 3.7% in the stock Monday following reports that said Trump administration officials were discussing taking a 10% stake in the company. A 10% stake would make the government one of the company’s largest shareholders.

Home Depot rose 3.2% after second-quarter earnings and revenue missed analysts’ expectations. Still, the home-improvement retailer said it continues to expect fiscal-year sales to rise 2.8% and comparable-store sales to increase about 1%.

Palo Alto Networks rose 3.1% after reporting fiscal fourth-quarter earnings that topped analysts’ estimates and issuing first-quarter and fiscal 2026 guidance that also was better than forecasts.

The cybersecurity company said it expects adjusted profit in the fiscal year of $3.75 to $3.85 a share, better than the consensus call for $3.68. Palo Alto also sees fiscal 2026 next-generation security annual recurring revenue of $7 billion to $7.1 billion for year-over-year growth of between 26% and 27%.

Medtronic was down 3.1% even as the medical-device maker posted better-than-expected quarterly earnings and appointed two new board directors following talks with activist investor Elliott Investment Management.

Fabrinet, the contract electronics manufacturer, reported fiscal fourth-quarter earnings and revenue that beat expectations. It also forecast current-quarter revenue of between $910 million and $950 million, a range whose midpoint is higher than the consensus forecast among analysts. The stock, however, declined 13%.

Drugmaker Viking Therapeutics fell 42% after releasing results of a study of its experimental weight-loss pill, indicating the data were worse than investors’ expectations. In a mid-stage clinical trial, VK2735, which is taken once daily as a pill, resulted in an average weight reduction of 12.2% in patients taking the highest dose over a 13-week period. Patients on placebo lost 1.3% of their weight. Nearly a third of patients discontinued the treatment, suggesting side effects could be a concern.

Palantir Technologies declined 9.4%. The company, which sells artificial-intelligence software to manage and analyze large amounts of data, was the worst performer in the S&P 500. Shares have fallen for five straight sessions.

XPeng rose 4.2% in U.S. trading after the Chinese maker of electric vehicles posted a second-quarter loss that narrowed from a year earlier. Revenue rose 125% from a year earlier.

Tegna rose 4.4% after Nexstar Media Group reached an agreement to acquire the TV station operator in an all-cash deal worth $6.2 billion. The news follows a report from The Wall Street Journal that said Sinclair offered to merge its broadcast TV business with Tegna. Nextstar fell 1.3%. Sinclair was down 1.1%.

Write to Joe Woelfel at joseph.woelfel@barrons.com